Interim Clinical Commissioning Policy: Tocilizumab for hospitalised patients with COVID-19 pneumonia (adults)

Document first published:
Page updated:
Publication type:

The proposal is: tocilizumab is recommended to be available as a treatment option through routine commissioning for adult patients (aged 18 years and older) hospitalised with COVID-19 in accordance with the criteria set out in this document.


Updated 12 September 2021.